Abstract

Pancreatic carcinoma has the poorest prognosis in all the digestive cancers, and the management remains challenging. Nowadays the treatment strategy of pancreatic carcinoma has been changed from first into the mode of multi-disciplinary team (MDT) with surgery as a leading and crucial position. By historical review, some issues related to the strategy of borderline resectable pancreatic carcinoma, including value of neoadjuvant therapy, perioperative complications, laparoscopic pancreaticoduodenectomy were discussed and commentated. The breakthrough for managing pancreatic carcinoma will be based on early diagnosis and the development of biologic targeting therapy. The surgeons′ concept should constantly advance with the times, and the strategy pattern should be converted from local to system, from morphology to biology, and from surgery to oncology. Key words: Pancreatic neoplasms; Neoadjuvant the-rapy; Complication; Pancreaticoduodenectomy; Laparoscopy

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.